×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
ETR:AFX

Carl Zeiss Meditec Stock Forecast, Price & News

€115.75
+1.85 (+1.62%)
(As of 07/1/2022 12:00 AM ET)
Add
Compare
Today's Range
€111.25
€115.75
50-Day Range
€105.45
€129.95
52-Week Range
€104.55
€202.00
Volume
67,330 shs
Average Volume
94,405 shs
Market Capitalization
$10.35 billion
P/E Ratio
38.46
Dividend Yield
0.78%
Price Target
€181.13

Carl Zeiss Meditec MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
56.5% Upside
€181.13 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.16 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive AFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

Carl Zeiss Meditec logo

About Carl Zeiss Meditec (ETR:AFX) Stock

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

AFX Stock News Headlines

CARL ZEISS MEDITEC AG (AFX.MU)
CARL ZEISS MEDITEC AG (AFX.DU)
Carl Zeiss Meditec AG Inhaber-A (AFX.SG)
See More Headlines

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
3,531
Year Founded
N/A

Company Calendar

Today
7/04/2022
Next Earnings (Estimated)
8/05/2022

Price Target and Rating

Average Stock Price Forecast
€181.13
High Stock Price Forecast
€215.00
Low Stock Price Forecast
€146.00
Forecasted Upside/Downside
+56.5%
Consensus Rating
N/A
Rating Score (0-4)
0
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.73 billion
Cash Flow
€0.09 per share
Book Value
€19.34 per share

Miscellaneous

Free Float
N/A
Market Cap
$10.35 billion
Optionable
Not Optionable
Beta
N/A














Carl Zeiss Meditec Frequently Asked Questions

What is Carl Zeiss Meditec's stock price forecast for 2022?

0 Wall Street research analysts have issued 1 year price objectives for Carl Zeiss Meditec's shares. Their AFX stock forecasts range from €146.00 to €215.00. On average, they anticipate Carl Zeiss Meditec's stock price to reach €181.13 in the next year. This suggests a possible upside of 56.5% from the stock's current price.
View analysts' price targets for Carl Zeiss Meditec
or view top-rated stocks among Wall Street analysts.

How has Carl Zeiss Meditec's stock price performed in 2022?

Carl Zeiss Meditec's stock was trading at €184.85 at the beginning of the year. Since then, AFX shares have decreased by 37.4% and is now trading at €115.75.
View the best growth stocks for 2022 here
.

When is Carl Zeiss Meditec's next earnings date?

Carl Zeiss Meditec is scheduled to release its next quarterly earnings announcement on Friday, August 5th 2022.
View our earnings forecast for Carl Zeiss Meditec
.

Is Carl Zeiss Meditec a good dividend stock?

Carl Zeiss Meditec(ETR:AFX) pays an annual dividend of €0.90 per share and currently has a dividend yield of 0.78%. The dividend payout ratio of Carl Zeiss Meditec is 29.90%. This payout ratio is at a healthy, sustainable level, below 75%.

Who are Carl Zeiss Meditec's key executives?

Carl Zeiss Meditec's management team includes the following people:
  • Mr. Justus Felix Wehmer, CFO & Member of the Management Board (Age 57, Pay $564.5k)
  • Mr. Jan Willem de Cler, Member of Management Board
  • Dr. Markus Weber, Pres, CEO & Chairman of Management Board
  • Mr. Sebastian Frericks, Director of Investor Relations
  • Mr. Martin Wiechmann, Head of the Planetarium Bus. Unit
  • Mr. Mike Wang, Head of Marketing - Shanghai
  • Mr. Steven C. Schallhorn M.D., Chief Medical Officer for Global Ophthalmic Devices
  • Mr. Andrew Chang, Head of Sales for Ophthalmic Devices & Pres of Carl Zeiss Meditec, Inc.
  • Laurie Ferguson, Head of Global Communications Ophthalmic Devices
  • Dr. Euan S. Thomson Ph.D., Pres of Ophthalmic Devices & Head of the Ophthalmic Devices Strategic Bus. Unit (Age 59)

What other stocks do shareholders of Carl Zeiss Meditec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Carl Zeiss Meditec investors own include Covestro (1COV), AbbVie (ABBV), AmerisourceBergen (ABC), Allianz (ALV), Daimler (DAI), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM) and SAP (SAP).

What is Carl Zeiss Meditec's stock symbol?

Carl Zeiss Meditec trades on the ETR under the ticker symbol "AFX."

What is Carl Zeiss Meditec's stock price today?

One share of AFX stock can currently be purchased for approximately €115.75.

How much money does Carl Zeiss Meditec make?

Carl Zeiss Meditec (ETR:AFX) has a market capitalization of $10.35 billion and generates $1.73 billion in revenue each year.

How many employees does Carl Zeiss Meditec have?

Carl Zeiss Meditec employs 3,531 workers across the globe.

How can I contact Carl Zeiss Meditec?

Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The official website for Carl Zeiss Meditec is www.zeiss.com. The company can be reached via phone at +49-3641-2200.

This page (ETR:AFX) was last updated on 7/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.